Migraine without aura and Migraine with typical aura
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Meets the diagnostic criteria for migraine without aura or migraine with typical aura, and satisfies the unilateral, pulsating headache characteristics as specified in the diagnosis: This headache episode is a migraine attack and meets the unilateral, pulsating headache features; 2. The VAS score for this headache episode is =4; 3. The number of monthly migraine attacks is less than 15 days; 4. Aged 18-65 years (including 18 and 65 years), with an initial onset age less than 50 years, and has a history of migraine for more than one year; 5. Has not taken any migraine treatment medications within 24 hours of this episode, or the medications taken were ineffective; 6. Participants taking migraine preventive medications should have received a stable dose of no more than one preventive drug for at least 2 months prior to enrollment; 7. No prior acupuncture treatment; 8. The patient voluntarily participates and signs, or has a first-degree relative sign, the informed consent form. Note: For individuals where intracranial organic diseases cannot be ruled out, a cranial CT or MRI examination should be conducted to exclude headaches caused by intracranial organic diseases.
Exclusion criteria
Exclusion criteria: 1.Long-term users of painkillers or those dependent on painkillers (taking painkillers for more than 10 days within 1 month), or those with alcohol or drug abuse; 2. Patients with secondary headaches; 3.Patients who have undergone superficial temporal artery-middle cerebral artery anastomosis, superficial temporal artery ligation, or trauma to the pulsation site of the superficial temporal artery, making it impossible to complete superficial temporal artery ultrasound; 4. Patients with severe primary diseases of the cardiovascular, liver, kidney, digestive, or hematopoietic systems; 5. Patients with a history of epilepsy, stroke, or other organic neurological diseases, or a history of mental illness; 6. Patients with cognitive impairments who are unable to read or understand the content of the scale, unable to cooperate with medical treatment, may have poor compliance (i.e., unable to treatment), or are difficult to complete efficacy assessment; 7. Patients prone to infections, or those with skin diseases or skin damage at the acupuncture site; 8. Patients with a history of bleeding disorders caused by deficiency or dysfunction of clotting factors; 9. Pregnant and breastfeeding women; 10. Patients currently participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The percentage of patients whose headaches disappeared within 2 hours; | — |
Secondary
| Measure | Time frame |
|---|---|
| After acupuncture treatment for 2 hours, the change in headache severity VAS score compared to baseline.;After acupuncture treatment for 2 hours, the ratio of pain-free patients to those with headache relief (headache relief defined as no headache or mild headache).;The ratio of patients with persistent headache-free status to those with persistent headache relief from 2-hour to 24-hour.;Changes in VAS scores for pain in patients at the onset of a migraine attack and immediately after acupuncture treatment, as well as 5, 10, 20, 30, 45, 60, and 90 minutes, and 2, 3, 4, 6, 8, 24, and 48 hours after treatment.;At the onset of a migraine attack and immediately after acupuncture treatment, as well as 5, 10, 20, 30, 45, 60, and 90 minutes, and 2, 3, 4, 6, 8, 24, and 48 hours after treatment, the disappearance rate of the most bothersome accompanying symptoms, such as nausea, vomiting, photophobia, and phonophobia, compared to baseline in patients.;The 48-hour headache recurrence rate, defined as no pain occurring within 2 hours after treatment completion and the occurrence of headache of any intensity within 48 hours after acupuncture treatment.;The proportion of users of acute analgesics;Blind evaluation refers to, after treatment ends, asking patients to judge their group assignment based on their treatment experience, and comparing the results between the two groups to determine if there are inter-group differences.; | — |
Countries
China
Contacts
Beijing University of Chinese Medicine Dongzhimen Hospital